Drug Name:Liraglutide
Drug Class:Glucagon-like peptide-1 (GLP-1) receptor agonist
Mechanism of Action:
  • Activates GLP-1 receptors in the pancreas, leading to increased insulin secretion
  • Slows gastric emptying, reducing postprandial glucose levels
  • Reduces glucagon secretion, leading to decreased hepatic glucose production
Use:
  • Type 2 diabetes mellitus
  • Obesity
Side Effects:
  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Hypoglycemia (when used with insulin or sulfonylureas)
Contraindications:
  • History of medullary thyroid carcinoma
  • Multiple endocrine neoplasia syndrome type 2
  • Pregnancy
Specialty:
  • Endocrinology
  • Internal Medicine